Mentice Receives Grant from Sweden’s Innovation Agency to Improve Synthetic Image Generation

GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ — Mentice has received a 3 million SEK grant from the Swedish government agency for innovation, Vinnova, to improve realism in Mentice virtual reality software environment with a focus on synthetic image generation. Mentice will be a part of a joint European research project called the TASTI project, financed by Vinnova within the Eureka Xecs cluster.  

“The work to be done in the scope of the TASTI project will further increase the realism of our solutions in several ways. It will not only improve our current products but will open doors to new applications, where our synthetic images are used to train medical AI algorithms, fully in line with Mentice ambitions to further enhance our position as the most innovative decision support solutions,” says Henrik Storm, Chief Technology Officer at Mentice.  

For more information, please contact:  

Henrik Storm, Chief Technology Officer, Mentice  
E-mail: [email protected]

The following files are available for download:

https://mb.cision.com/Main/18275/3664114/1659233.pdf

Mentice Receives Grant from Sweden’s Innovation Agency to Improve Synthetic Image Generation

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.